DT Cloud Acquisition Corp. ( (DYCQ) ) has shared an update.
DT Cloud Acquisition Corporation and Maius Pharmaceutical Co., Ltd. have announced a definitive business combination agreement, setting the stage for Maius to become a wholly-owned subsidiary of a new holding company, Maius Pharmaceutical Group Co., Ltd., which will be listed on Nasdaq. With an equity value of $250 million, the merger focuses on expanding Maius’s innovative drug development in anticancer, autoimmune, and anti-infective areas. The transaction, expected to close in the first half of 2025, is subject to regulatory and shareholder approvals, promising exciting investment opportunities in the biopharmaceutical sector.
Learn more about DYCQ stock on TipRanks’ Stock Analysis page.
